Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents.
D000808:Angiotensinogen / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000378:metabolism / Q000494:pharmacology*; D016282:Aspartic Acid Endopeptidases; D001665:Binding Sites; D010450:Endopeptidases; D006801:Humans; D066298:In Vitro Techniques; D008958:Models, Molecular; D008968:Molecular Conformation; D009842:Oligopeptides / Q000378:metabolism / Q000494:pharmacology; D010434:Pepsin A / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors; D000092502:Renin Inhibitors
D000808:Angiotensinogen; D000959:Antihypertensive Agents; D016282:Aspartic Acid Endopeptidases; D010450:Endopeptidases; D009842:Oligopeptides; D010434:Pepsin A; D011480:Protease Inhibitors; D000092502:Renin Inhibitors; C054285:H 256; C039583:H 142